247 related articles for article (PubMed ID: 27022768)
21. IL-33 deficiency slows cancer growth but does not protect against cisplatin-induced AKI in mice with cancer.
Ravichandran K; Holditch S; Brown CN; Wang Q; Ozkok A; Weiser-Evans MC; Nemenoff R; Miyazaki M; Thiessen-Philbrook H; Parikh CR; Ljubanovic D; Edelstein CL
Am J Physiol Renal Physiol; 2018 Mar; 314(3):F356-F366. PubMed ID: 29070568
[TBL] [Abstract][Full Text] [Related]
22. The effect of sildenafil on cisplatin nephrotoxicity in rats.
Ali BH; Abdelrahman AM; Al-Salam S; Sudhadevi M; AlMahruqi AS; Al-Husseni IS; Beegam S; Dhanasekaran S; Nemmar A; Al-Moundhri M
Basic Clin Pharmacol Toxicol; 2011 Oct; 109(4):300-8. PubMed ID: 21575139
[TBL] [Abstract][Full Text] [Related]
23. Urinary cystatin C as a biomarker for acute kidney injury and its immunohistochemical localization in kidney in the CDDP-treated rats.
Togashi Y; Sakaguchi Y; Miyamoto M; Miyamoto Y
Exp Toxicol Pathol; 2012 Nov; 64(7-8):797-805. PubMed ID: 21377848
[TBL] [Abstract][Full Text] [Related]
24. Celecoxib, a selective cyclooxygenase-2 inhibitor, attenuates renal injury in a rat model of Cisplatin-induced nephrotoxicity.
Suddek GM; El-Kenawi AE; Abdel-Aziz A; El-Kashef HA
Chemotherapy; 2011; 57(4):321-6. PubMed ID: 21893983
[TBL] [Abstract][Full Text] [Related]
25. Comparative study of allogenic and xenogeneic mesenchymal stem cells on cisplatin-induced acute kidney injury in Sprague-Dawley rats.
Ashour RH; Saad MA; Sobh MA; Al-Husseiny F; Abouelkheir M; Awad A; Elghannam D; Abdel-Ghaffar H; Sobh M
Stem Cell Res Ther; 2016 Sep; 7(1):126. PubMed ID: 27585525
[TBL] [Abstract][Full Text] [Related]
26. Protective effects of relaxin against cisplatin-induced nephrotoxicity in rats.
Yoshida T; Kumagai H; Kohsaka T; Ikegaya N
Nephron Exp Nephrol; 2014; 128(1-2):9-20. PubMed ID: 25403022
[TBL] [Abstract][Full Text] [Related]
27. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
Wainford RD; Weaver RJ; Stewart KN; Brown P; Hawksworth GM
Toxicology; 2008 Jul; 249(2-3):184-93. PubMed ID: 18583013
[TBL] [Abstract][Full Text] [Related]
28. The Doppler renal resistive index for early detection of acute kidney injury after hip fracture.
Marty P; Ferre F; Labaste F; Jacques L; Luzi A; Conil JM; Silva S; Minville V
Anaesth Crit Care Pain Med; 2016 Dec; 35(6):377-382. PubMed ID: 27133237
[TBL] [Abstract][Full Text] [Related]
29. Serum cystatin C for acute kidney injury evaluation in children treated with aminoglycosides.
Lau L; Al-Ismaili Z; Harel-Sterling M; Pizzi M; Caldwell JS; Piccioni M; Lands LC; Mottes T; Devarajan P; Goldstein SL; Bennett MR; Zappitelli M
Pediatr Nephrol; 2017 Jan; 32(1):163-171. PubMed ID: 27743042
[TBL] [Abstract][Full Text] [Related]
30. Role of urine neutrophil gelatinase-associated lipocalin in the early diagnosis of amphotericin B-induced acute kidney injury.
Rocha PN; Macedo MN; Kobayashi CD; Moreno L; Guimarães LH; Machado PR; Badaró R; Carvalho EM; Glesby MJ
Antimicrob Agents Chemother; 2015 Nov; 59(11):6913-21. PubMed ID: 26303800
[TBL] [Abstract][Full Text] [Related]
31. Cisplatin-Induced Non-Oliguric Acute Kidney Injury in a Pediatric Experimental Animal Model in Piglets.
Santiago MJ; Fernández SN; Lázaro A; González R; Urbano J; López J; Solana MJ; Toledo B; Del Castillo J; Tejedor A; López-Herce J
PLoS One; 2016; 11(2):e0149013. PubMed ID: 26871589
[TBL] [Abstract][Full Text] [Related]
32. The abrupt pathological deterioration of cisplatin-induced acute kidney injury: Emerging of a critical time point.
Gong Q; Wang M; Jiang Y; Zha C; Yu D; Lei F; Luo Y; Feng Y; Yang S; Li J; Du L
Pharmacol Res Perspect; 2021 Dec; 9(6):e00895. PubMed ID: 34817124
[TBL] [Abstract][Full Text] [Related]
33. Pre-procedural renal resistive index accurately predicts contrast-induced acute kidney injury in patients with preserved renal function submitted to coronary angiography.
Wybraniec MT; Bożentowicz-Wikarek M; Chudek J; Mizia-Stec K
Int J Cardiovasc Imaging; 2017 May; 33(5):595-604. PubMed ID: 27995343
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the protective effect of agmatine against cisplatin nephrotoxicity with 99mTc-DMSA renal scintigraphy and cystatin-C.
Salihoglu YS; Elri T; Gulle K; Can M; Aras M; Ozacmak HS; Cabuk M
Ren Fail; 2016 Oct; 38(9):1496-1502. PubMed ID: 27604130
[TBL] [Abstract][Full Text] [Related]
35. Doppler sonography in experimentally induced acute renal failure in rabbits. Resistive index versus serum creatinine levels.
Yoon DY; Kim SH; Kim HD; Na DG; Goo JM; Choi HJ; Yeon KM; Han MC
Invest Radiol; 1995 Mar; 30(3):168-72. PubMed ID: 7797415
[TBL] [Abstract][Full Text] [Related]
36. Protease-activated receptor 2 exacerbates cisplatin-induced nephrotoxicity.
Watanabe M; Oe Y; Sato E; Sekimoto A; Sato H; Ito S; Takahashi N
Am J Physiol Renal Physiol; 2019 Apr; 316(4):F654-F659. PubMed ID: 30672316
[TBL] [Abstract][Full Text] [Related]
37. Protective effect of tonapofylline (BG9928), an adenosine A1 receptor antagonist, against cisplatin-induced acute kidney injury in rats.
Gill A; Wortham K; Costa D; Davis W; Ticho B; Whalley E
Am J Nephrol; 2009; 30(6):521-6. PubMed ID: 19828940
[TBL] [Abstract][Full Text] [Related]
38. Sex differences in protective effect of recombinant human erythropoietin against cisplatin-induced nephrotoxicity in rats.
Eshraghi-Jazi F; Nematbakhsh M; Pezeshki Z; Nasri H; Talebi A; Safari T; Mansouri A; Mazaheri S; Ashrafi F
Iran J Kidney Dis; 2013 Sep; 7(5):383-9. PubMed ID: 24072151
[TBL] [Abstract][Full Text] [Related]
39. Effect of rosiglitazone on cisplatin-induced nephrotoxicity.
Ozkaya O; Yavuz O; Can B; Dilek M; Savli E; Acikgoz Y; Bedir A; Akpolat T
Ren Fail; 2010 Jan; 32(3):368-71. PubMed ID: 20370454
[TBL] [Abstract][Full Text] [Related]
40. Human umbilical cord mesenchymal stem cells attenuate cisplatin-induced acute and chronic renal injury.
Peng X; Xu H; Zhou Y; Wang B; Yan Y; Zhang X; Wang M; Gao S; Zhu W; Xu W; Qian H
Exp Biol Med (Maywood); 2013 Aug; 238(8):960-70. PubMed ID: 23970411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
